US Patent Issued to Seattle Children's Hospital on July 15 for "Methods of exogenous drug activation of chemical-induced signaling complexes expressed in engineered cells in vitro and in vivo" (Washington Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,970, issued on July 15, was assigned to Seattle Children's Hospital (Seattle).

"Methods of exogenous drug activation of chemical-induced signaling complexes expressed in engineered cells in vitro and in vivo" was invented by Andrew M. Scharenberg (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to compositions comprising fusion proteins and cells expressing the proteins. The application further relates to methods of using the fusion proteins, cells, and compositions for modulating cell signaling and for selective expansion of cells."

The patent was filed on Aug. 8, 2023, under Application No. 18/446,018.

*For...